ChooQ.L., KuoG., WeinerA.J., OverbyL.R., BradleyD.W., HoughtonM.. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome.Science1989; 244: 359–61.
2.
AlterM.J., HadlerS.C., JudsonF.N.. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.JAMA1990; 264: 2231–5.
3.
KuoG., ChooQ.L., AlterH.J.. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.Science1989; 244: 362–4.
4.
SimonN., CouroucéA.M., LemarrecN., TrepoC., DucampS.. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.Kidney Int1994; 46: 504–11.
5.
DenticoP., BuongiornoR., VolpeA.. Prevalence and incidence of hepatitis C virus in hemodialysis patients: study of risk factors.Clin Nephrol1992; 38: 49–52.
6.
LombardiM., CerraiT., GeattiS.. Results of a national epidemiological investigation on HCV infection among dialysis patients.J Nephrol1999; 12: 322–7.
7.
JadoulM., CornuC., Van Ypersele deStrihou, and the Universitaries Cliniques St-Luc (UCL) Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian multicenter study.Kidney Int1998; 53: 1022–5.
8.
Pinto dos SantosJ., LoureiroA., Cendoroglo NetoM., PereiraB.J.G.. Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units.Nephrol Dial Transplant1996; 11: 2017–22.
9.
SalamaG., RostaingL., SandresK., IzopetJ.. Hepatitis C virus infection in French hemodialysis units: a multicenter study.J Med Virol2000; 61: 44–51.
10.
LimidoA., ConteF., MalbertiF., SpottiD., MarcelliD., LocatelliF.. Misure di profilassi delle infezioni da virus B e C in Lombardia: Dati del Registro Lombardo Dialisi e Trapianto (RLDT) (Abstract).Giorn It Nefrol2000; 17: 266.
11.
SchneebergerP.M., KeurI., van der VlietW.. Hepatitis C virus infection in dialysis centers in The Netherlands: a national survey by serological and molecular methods.J Clin Microbiology1998; 36: 1711–5.
12.
IrishD., BlakeC., ChristophersJ.. Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: Implications for infection control and laboratory screening.J Med Virol1999; 59: 135–40.
13.
CovicA., IancuL., ApetreiC.. Hepatitis virus infection in haemodialysis patients from Moldavia.Nephrol Dial Transplant1999; 14: 40–5.
14.
Rais-JalaliG., KhajehdehiP.. Anti-HCV seropositivity among haemodialysis patients of Iranian origin (Letter).Nephrol Dial Transplant1999; 14: 2056–2057.
15.
SaynerA.A., ZeytinogluA., OzkahyaM.. HCV infection in haemodialysis and CAPD patients (Letter).Nephrol Dial Transplant1998; 14: 256–7.
16.
HassanA.A., KhalilR.. Hepatitis C in dialysis patients in Egypt: Relationship to dialysis duration, blood transfusion, and liver disease (Letter).Saudi J Kidney Dis Transplant2000; 11: 72–5.
17.
TodorovV., BonevaR., IlievaP., DoichinovaT., DonchevM.. High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria (Letter).Nephron1998; 79: 222–3.
18.
DjordjevicV., StojanovicK., StojanovicM., StefanovicV.. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study.Int J Artif Organs2000; 23: 181–8.
19.
ZamirD., StorchS., ZonderH., ZamirC., WeinerP.. Hepatitis C virus seroconversion and genotype prevalence in patients and staff on chronic hemodialysis.J Clin Gastroenterol1999; 28: 23–8.
20.
PujiolF.H., PonceI.G., LemaM.G.. High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.J Clin Microbiol1996; 34: 1633–6.
21.
FabriziF., BacchiniG., PontorieroG., GuarnoriI., ErbaG.F., LocatelliF.. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic hemodialysis patients: a study with second-generation assays.Nephrol Dial Transplant1993; 8: 744–7.
22.
HardyN.M., SandroniS., DanielsonS., WilsonW.J.. Antibody to hepatitis C virus increases with time on hemodialysis.Clin Nephrol1992; 38: 44–8.
23.
SchlipkoterU., OterU., RoggendorfM.. Hepatitis C virus antibodies in hemodialysis patients (Letter).Lancet1990; 335: 1409.
24.
ChanT.M., LokA.S.F., ChengI.K.P.. Hepatitis C infection among dialysis patients: A comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis.Nephrol Dial Transplant1991; 6: 944–7.
25.
GilliP., MorettiM., SoffrittiS.. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients.Int J Artif Organs1990; 13: 737–41.
26.
FabriziF., LunghiG., GuarnoriI.. Hepatitis C virus genotypes in chronic dialysis patients.Nephrol Dial Transplant1996; 11: 679–83.
27.
OkamotoH., KojimaM., OkadaS.I.. Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability.Virology1992; 190: 894–9.
28.
SimmondsP.. Variability of hepatitis C virus.Hepatology1995; 21: 570–83.
29.
OkamotoH., SugiyamaY., OkadaS.. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources.J Gen Virol1993; 73: 673–9.
30.
KurosakiM., EnomotoN., MarumoF., SatoC.. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection.Hepatology1993; 18: 1293–9.
31.
McOmishF., ChanS.W., DowB.C.. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serological reactivity and rate of alanine aminotransferase abnormalities.Transfusion1993; 33: 7–13.
32.
NakaoT., EnomotoN., TakadaN., TakadaA., DateT.. Typing of hepatitis C virus genomes by restriction fragment length polymoprhism.J Gen Virol1991; 72: 2105–12.
33.
StuyverL., RossauR., WyseurA.. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.J Gen Virol1993; 74: 1093–102.
34.
NordenfeldtE., LofgrenB., WidellA.. Hepatitis C virus infection in hemodialysis patients in southern Sweden: Epidemiological, clinical, and diagnostic aspects.J Med Virol1993; 40: 266–70.
35.
FornsX., Fernandez-LlamaP., PonsM.. Incidence and risk factors of hepatitis C virus infection in a hemodialysis unit.Nephrol Dial Transplant1997; 12: 736–40.
36.
PowerJ.P., LawlorE., DavidsonF., HolmesE.C., YapP.L., SimmondsP.. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin.Lancet1995; 345: 1211–3.
37.
ChayamaK., KobayashiM., TsubotaA.. Molecular analysis of intraspousal transmission of hepatitis C virus.J Hepatol1995; 22: 431–9.
38.
AllanderT.G., GruberA., NaghaviM.. Frequent patient-to-patient transmission of hepatitis C virus in a hematology ward.Lancet1995; 345: 603–7.
39.
AllanderT., MedinS., JacobsonS.H., GrillnerL., PerssonM.A.A.. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment.J Med Virol1994; 43: 415–9.
40.
SampietroM., BadalamentiS., SalvadoriS.. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: Evidence for nosocomial transmission of HCV.Kidney Int1995; 47: 911–7.
41.
ZeuzemS.E., ScheuermannE.H., WaschkD.. Phylogenetic analysis of hepatitis C virus isolation from hemodialysis patients.Kidney Int1996; 49: 896–902.
42.
OgataN., AlterH.J., MillerR.H., PurcellR.H.. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus.Proc Natl Acad Sci USA1991; 88: 2292–6.
43.
MizunoM., HiguchiT., KanmatsuseK., EsumiM.. Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units.J Clin Microbiol1998; 36: 2926–31.
44.
IrieY., HayashiH., YokozekiK., KashimaT., OkudaK.. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients.J Hepatol1994; 20: 557–9.
45.
MunroJ., BriggsJ.D., McCrudenE.A.B.. Detection of a cluster of hepatitis C infections in a renal transplant unit by analysis of sequence variation of the NS5 gene.J Infect Dis1996; 174: 177–80.
46.
StuyverL., ClaeysH., WyseurA.. Hepatitis C virus in a hemodialysis unit: Molecular evidence for nosocomial transmission.Kidney Int1996; 49: 889–95.
47.
KatsoulidouA., ParaskevisD., KalapothakiV., ArvanitisD., KaryannisP., HadjiconstantinouV., HatzakisA., for the Multicenter Haemodialysis Cohort Study on Viral Hepatitis. Molecular epidemiology of a hepatitis C outbreak in a haemodialysis unit.Nephrol Dial Transplant1999; 14: 1188–94.
48.
IzopetJ., PasquierC., SandresK., PuelJ., RostaingL.. Molecular evidence for nosocomial transmission of hepatitis C virus in a Trench hemodialysis unit.J Med Virol1999; 58: 139–44.
49.
Le PogamS., Le ChapoisD., ChristenR., DuboisF., BarinF., GoudeauA.. Hepatitis C in a hemodialysis unit: molecular evidence for nososcomial transmission.J Clin Microbiol1998; 36: 3040–3.
50.
McLaughlinK.J., CameronS.O., GoodT.. Nosocomial transmission of hepatitis C virus within a British dialysis centre.Nephrol Dial Transplant1997; 12: 304–9.
51.
NorderH., BergstromA., UhnooI.. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region.J Clin Microbiol1998; 36: 3066–9.
52.
OlmerM., BouchouarebD., ZandottiC., De MiccoP., De LamballerieX.. Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial transmission.Clin Nephrol1996; 47: 263–70.
53.
De LamballerieX., OlmerM., BouchouarebD., ZandottiC., De MiccoP.. Nosocomial transmission of hepatitis C in hemodialysis patients.J Med Virol1996; 49: 296–302.
54.
GretheS., GemsaF., MonazahianM., BohmeI., UyA., ThomssenR.. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: Direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis.J Med Virol2000; 60: 152–8.
55.
OuC.Y., CiesielskiC.A., MyersG., Laboratory Investigation Group, Epidemiologic Investigation Group. Molecular epidemiology of HIV transmission in a dental practice.Science1992; 256: 1165–71.
56.
BergerH., WeiserB., FlahertyK., GullaJ., NguyenP.N., GibbsR.A.. Evolution of human immunodeficiency virus type 1 nucleotide sequence diversity among close contacts.Proc Natl Acad Sci USA1991; 88: 11336–40.
57.
SmithD.B., SimmondsP.. Review: Molecular epidemiology of hepatitis C virus.J Gastroenterol Hepatol1997; 12: 522–7.
58.
OdebergJ., YunZ., SonenborgA., UhlenM., LundebergJ.. Dinamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing.J Clin Microbiol1995; 33: 1870–4.
59.
McCrudenE.A.B., MunroJ., KingB., FitzpatrickS., BriggsJ.D.. Patient-to-patient transmission of hepatitis C virus.Lancet1995; 345: 1443–4.
60.
SuzukiK., MizokamiM., LauJ.Y.. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis.J Infect Dis1994; 170: 1575–8.
61.
VasileA., AllegraV., CancianiD., ForchiG., MengozziG.. Prospective and retrospective assessment of clinical and laboratory parameters in maintenance hemodialysis patients with and without HCV antibodies.Nephron1992; 61: 318–9.
62.
BessoL., RovereA., PeanoG.. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit.Nephron1992; 61: 304–6.
63.
OguchiH., MiyasakaM., TokunagaS.. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.Clin Nephrol1992; 38: 36–43.
64.
KiyosawaK., SodeyamaT., TanakaE.. Hepatitis C in hospital employees with needlestick injuries.Ann Intern Med1991; 115: 367–9.
65.
CarianiE., ZonaroA., PrimiD.. Detection of HCV RNA and antibodies to HCV after needkestick injury (Letter).Lancet1991; 337: 850.
66.
EstebanJ.I., GomezJ., MartellM.. Transmission of hepatitis C virus by a cardiac surgeon.N Engl J Med1996; 334: 555–60.
67.
HungK.Y., ChenW.Y., YangC.S., LeeS.H., WuD.J.. Hepatitis B and C in hemodialysis patients.Dial Transplant1995; 24: 135–9.
68.
LinH.H., HuangC.C., SheenI.S., LinD.Y., LiawY.F.. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.Am J Nephrol1991; 11: 192–4.
69.
JadoulM., CornuC., Van Ypersele de StrihouC., and the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: A prospective study.Kidney Int1993; 44: 1322–5.
70.
SampietroM., GrazianiG., BadalamentiS.. Detection of hepatitis C virus in dialysate and in blood ultrafiltrate of HCV-positive patients (Letter).Nephron1994; 68: 140.
71.
LombardiM., CerraiT., DattoloP.. Is the dialysis membrane a safe barrier against HCV infection?(Letter) Nephrol Dial Transplant1995; 10: 578–9.
72.
ValtuilleR., FernandezJ.L., BerridiJ.. Evidence of hepatitis C virus passage across dialysis membranes.Nephron1998; 80: 194–6.
73.
HubmannR., ZazgornikJ., GabrielC., GarbeisB., BlauhutB.. Hepatitis C virus- does it penetrate the haemodialysis membrane ?Nephrol Dial Transplant1995; 10: 541–2.
74.
CarameloC., NavasS., AlberolaM.L., BermejilloT., ReyeroA., CarrenoV.. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.Nephron1994; 66: 470–3.
75.
ManziniP., AmoreA., BrunettoM.R.. Is hepatitis C virus RNA detectable in dialysis ultrafiltrate?(Letter) Nephron1996; 72: 102–3.
76.
GladziwaU., SchlipkoterU.. Evidence of hepatitis C virus infection in peritoneal fluid but not in dialysate and ultrafiltrate or hemofiltrate (Letter).Nephron1995; 71: 98.
77.
MitwalliA., Al-MohayaS., Al WakeelJ.. Hepatitis C in chronic renal failure patients.Am J Nephrol1992; 12: 288–91.
78.
ChiaramonteS., TaggerA., RiberoM.L., GrossiA., MilanM., La GrecaG.. Prevention of viral hepatitis in dialysis units: isolation and technical management of dialysis.Nephron1992, 61: 287–9.
79.
BlumbergA., ZehnderC., BurckhardtJ.J.. Prevention of hepatitis C infection in haemodialysis units. A prospective study.Nephrol Dial Transplant1995; 10: 230–3.
80.
FabriziF., LunghiG., GuarnoriI.. Incidence of seroconversion for hepatitis C virus in chronic hemodialysis patients: a prospective study.Nephrol Dial Transplant1994; 9: 1611–5.
81.
CerraiT., TotiG., MichelassiS., ZignegoA.L., LombardiM.. Universal precautions and dedicated machines as cheap and effective measures to control HCV spread in haemodialysis centers.EDTNA/ERCA J1997; XXIII: S1–S14.
82.
AucellaF., VigilanteM., ValenteG., StalloneC.. Systematic monitor disinfection is effective in limiting HCV spread in hemodialysis.Blood Purif2000; 18: 110–4.
83.
NiuM.T., AlterM.J., KristensenC., MargolisH.S.. Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C.Am J Kidney Dis1992; 19: 345–52.
84.
SuzukiE., KanekoS., UdonoT.. Absence of nonpercutaneous transmission of hepatitis C virus in a colony of chimpanzees.J Med Virol1993; 39: 286–91.
85.
ValliM.B., CarloniG., ManzinA.. Hepatitis C virus infection of a VERO cell clone displaying efficient virus-cell binding.Res Virol1997; 148: 181–6.
86.
ClementiM.. Effect of a chlorine disinfectant on hepatitis C virus (HCV) in vitro: analysis of HCV binding to the cell surface receptors and analysis of viral replication.Acta Toxicologica et Therapeutica1997; XVIII: 25–31.
87.
ClementiM., RiccolaS.. Effect of the disinfectant AMU250 vs. hepatitis C virus (HCV) in vitro.Acta Toxicologica et Therapeutica1999; XX: 45–52
88.
DegremontA., VaillantP., ColletM., ManN.K.. Eradication of biofilm by a procedure including cleaning and autoclavage (Abstract).Am J Nephrol1998; 9: 170.
89.
BarrilG., BartoloméJ., TraverJ.A., CabrerizoM., SelgasR., CarrenoV.. Autoclaving eliminates hepatitis C virus from a hemodialysis monitor contaminated artificially.J Med Virol2000; 60: 139–43.
90.
CarameloC., de SequeraP., LopezM.D., OrtizA.. Hand-borne mechanisms of dissemination of hepatitis C virus in dialysis units: basis for new addenda to the present preventive strategies (Letter).Clin Nephrol1999; 51: 59–60.
91.
KellermanS., AlterM.J.. Preventing hepatitis B and C virus infections in end-stage renal disease patients: back to basics.Hepatology1999; 29: 291–3.
92.
Centers for Disease Control.Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease.MMWR1998; 47(No RR-19): 1–39
93.
OkudaK.H., HayashiH., KobayashiS., IrieY.. Mode of hepatitis C infection not associated with blood transfusions among chronic hemodialysis patients.J Hepatol1995; 23: 28–31.
94.
ArenasD.J., PayaJ.S.. Standard precautions in haemodialysis – the gap between theory and practice.Nephrol Dial Transplant1999; 14: 823–5.
95.
ArenasD.J., Sanchez-PayaJ., GonzalesC., RiveraF., AntolinA.. Audit on the degree of application of universal precautions in a haemodialysis unit.Nephrol Dial Transplant1999; 14: 1001–3.
96.
TokarsJ.L., MillerE.R., AlterM.J., ArduinoM.J.. National surveillance of dialysis associated diseases in the United States, 1995.ASAIO J1998; 44: 98–107.
97.
ArenasD.J., PayaJ.S., GonzalezC., RiveraF., EnriquezR.. Isolation of HCV patient is efficient in reducing the annual incidence of HCV infection, but is it really necessary?(Letter) Nephrol Dial Transplant1999; 14: 1337–9.
98.
DjordjevicV., StojanovicK., StojanovicM., StefanovicV.. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study.Int J Artif Organs2000; 23: 181–8.
99.
SemeK., PoljakM., Zuzec-ResekS., DebeljakM., DovcP., KorenS.. Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit.Nephron1997; 77: 273–8.
100.
VagelliG., CalabreseG., GuaschinoR., GonellaM.. Effect of HCV+ patients isolation on HCV infection incidence in a dialysis unit (Letter).Nephrol Dial Transplant1995; 1070–1.
101.
CuypersH.T.M., BrestersD., WinkelI.N.. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus.J Clin Microbiol1992; 30: 3320–4.
102.
WidellA., ManssonS., PerssonN.H., ThysellH., HermodssonS., BlohmeI.. Hepatitis C superinfection in hepatitis C virus (HCV) infected patients transplanted with an HCV-infected kidney.Transplantation1995, 60: 642–7.
103.
NatovS., LauJ.Y.N., BouthotB.A., and the New England Organ Bank Hepatitis C Study Group. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates.Am J Kidney Dis1998; 31: 920–7.
104.
GilliP., SoffrittiS., De Paoli VitaliE., BedaniP.L.. Prevention of hepatitis C virus in dialysis units.Nephron1995; 70: 301–6.